Bachem AG: Riding the “Golden Age of Peptides” with this Hidden Champion from Switzerland (opens in new tab)

Disclaimer: This is not investment advice. PLEASE DO YOUR OWN RESEARCH !!! Bachem is a 5 bn CHF market cap Swiss listed pharmaceutical/specialty chemical company which is the global market leader in the (outsourcing of) manufacturing of Polypeptide, a complex molecule and Active Pharmaceutical Ingredient (API) that is, among others, behind the blockbuster drugs Wegovy, Ozempic etc. Demand for those